AUSTRALIAN medical cannabis sales tanked by over a quarter in the second half of 2025, following a clampdown on the previous ‘profit before patient’ model A report from the Penington Institute shows that medical cannabis sales peaked in the second half of 2024 at 3.72m units before falling to 2.65m units in the second half…
A proposal for federal legalization of cannabis is now expected to be submitted to the White House by the end of the week, driving a bump in US cannabis stocks.
Virginia lawmakers have once again passed legislation aimed at establishing a regulated retail market for cannabis, but the bill faces a near-certain veto from Governor Glenn Youngkin, a staunch opponent of cannabis.
Less than 48 hours after Hawaii lawmakers appeared poised to legalize recreational cannabis, the state’s House of Representatives unexpectedly slammed the brakes, shelving the measure until at least 2026.
Hawaii’s latest efforts to legalize recreational cannabis are gaining momentum in the state legislature.
Florida is poised to have another shot at legalizing adult-use cannabis, reigniting hopes that the US’s third most populous state could yet become the trigger event for the cannabis industry many had anticipated last year.
South Dakota voters have a unique opportunity on Election Day. Already the country’s first electorate to see adult-use cannabis legalization measures in three straight election cycles, state voters could become the first to legalize recreational marijuana possession and cultivation without setting up a market for regulated sales.
Ongoing legal efforts to overturn the federal prohibition of cannabis received a welcome boon this week, as the appeals court scheduled a date for oral arguments to take place.
Writing for Business of Cannabis, Deborah Tharp, a cannabis-focused political consultant, campaign manager and legal researcher for Nugg and NuggMD, explains why it’s more crucial than ever not to overlook the stark differences between medical and recreational cannabis use.
